Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One power score. Smarter investment decisions
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
U.S. equity funds see large outflows as investors book profit
Sept 19 (Reuters) - Investors withdrew massive capital out of U.S. equity funds in the week to Sept. 17 as they turned cautious about the market's lofty valuations following the recent rally through a policy rate cut by the Federal Reserve and rushed to lock in profits.According to LSEG Lipper d...
Reuters
4 minutes ago
Global equity funds see a surge in weekly outflows
Sept 19 (Reuters) - Investors divested equity funds on a large scale in the week to September 17 to lock in profits as an extended record-setting rally in global stocks amid an interest rate cut by the Federal Reserve raised investor caution around the stock market's lofty valuations.Investors d...
Reuters
12 minutes ago
Esperion Therapeutics rises after partner Otsuka wins Japan approval for high cholesterol drug
** Shares of Esperion Therapeutics ESPR.O rise 3.6% to $2.84 premarket** ESPR says its partner, Otsuka Pharmaceutical, received approval from Japan's health ministry to market Nexletol, a cholesterol-lowering pill, for patients with high cholesterol and familial high cholesterol** Under its deal...
Reuters
13 minutes ago
Morgan Stanley Investment Management Announces Liquidation Of Calvert US Select Equity ETF
Sept 19 (Reuters) - Calvert US Select Equity ETF CVSE.PMORGAN STANLEY INVESTMENT MANAGEMENT ANNOUNCES LIQUIDATION OF CALVERT US SELECT EQUITY ETF (CVSE)
Reuters
18 minutes ago
Why Shares in Novo Nordisk Soared This Week
Key PointsThe oral version of Wegovy is proving to have similar efficacy, safety, and tolerability when compared to its injectable version. Clinical trial data suggest that Novo Nordisk's oral Wegovy is ahead of the pack, and it could receive FDA approval this year. 10 stocks we like better than Nov...
The Motley Fool
18 minutes ago
NYSE Content Advisory: Pre-Market Update + Russell 2000 hits first record since 2021
NEW YORK, Sept. 19, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2Yk...
PR Newswire
19 minutes ago
Got $1,000? 2 Stocks to Buy Now While They're on Sale
Key PointsYou can start investing with $1,000 by buying a few shares of Target (about $90 per share) and Lululemon (about $164).Target's premium store experience supports stronger margins than many big-box rivals.Lululemon is accelerating product innovation to reinvigorate sales growth.10 stocks we ...
The Motley Fool
24 minutes ago
U.S. STOCKS ON THE MOVE-Gold miners, Perpetua Resources, KalVista Pharmaceuticals
The Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refini.tv/3dKUyB8Wall Street's main indexes looked set for a subdued open on Friday after they rallied to record highs in the previous session, while FedEx rose as the parcel delivery firm posted upbeat ...
Reuters
26 minutes ago
This Unstoppable Healthcare Stock Just Made a Move in AI: Time to Buy?
Key PointsDrug giant Eli Lilly is launching an AI-powered drug discovery platform.While it won't generate any revenue, this initiative could pay off in the long run. Still, there are plenty of other reasons to invest in this major pharma stock. 10 stocks we like better than Eli Lilly › Recent breakt...
The Motley Fool
31 minutes ago
Massive News for Intel Stock Investors
In this video, I will talk about the recent deal between Intel (NASDAQ: INTC) and Nvidia and how it affects AMD stock investors. Watch the short video to learn more, consider subscribing, and click the special offer link below.*Stock prices used were from the trading day of Sept. 18, 2025. The video...
The Motley Fool
31 minutes ago
Verrica climbs after Japan's nod for skin infection drug
** Shares of Verrica Pharmaceuticals VRCA.O rise 18% to $4.78 premarket** Company says its partner Torii Pharmaceutical has received approval in Japan for their skin infection drug, Ycanth** The drug gets Japan's nod for the treatment of molluscum contagiosum — a common viral skin infection that...
Reuters
35 minutes ago
Lincoln National rises after Morgan Stanley upgrades to 'overweight'
** Insurance firm Lincoln National's LNC.N shares rise 3.5% to $41.20 premarket** Morgan Stanley upgrades LNC to "overweight" from "equal-weight"; raises PT to $58 from $41, representing 45.7% upside to stock's last close ** Brokerage says LNC's turnaround remains firmly...
Reuters
41 minutes ago
2 Dividend Powerhouses to Buy Right Now
Key PointsPepsiCo yields 4.02% after 53 straight years of dividend increases, using snack and beverage dominance to pass inflation directly to consumers.S&P Global's 0.71% yield looks tiny until you realize the 28.7% payout ratio leaves room for decades of double-digit growth.From Doritos to credit ...
The Motley Fool
46 minutes ago
Rivian vs. Lucid: Which EV Stock Is Winning in 2025?
Key PointsRivian and Lucid are charging ahead in the electric vehicle (EV) market.But the two EV makers have very different growth opportunities.As a result, one stock is the better value headed into 2026.10 stocks we like better than Lucid Group › Lucid Group (NASDAQ: LCID) and Rivian Automotive (N...
The Motley Fool
46 minutes ago
Baltic index heads for weekly gain on capesize strength
Sept 19 (Reuters) - The Baltic Exchange's dry bulk sea freight index, which monitors rates for vessels moving dry bulk commodities, edged down on Friday due to weakness in smaller vessel segments, but was set to post a weekly gain on capesize advances.* The main index .BADI, which factors in rat...
Reuters
47 minutes ago
ARS Pharma up after Japan's approval for allergic reaction nasal spray
** Drug developer ARS Pharmaceuticals' shares SPRY.O rise 7.7% to $10.69 premarket** Company says Japan's health regulator has approved its nasal spray, neffy, in 1 mg and 2 mg doses, for emergency treatment of allergic reactions in adults and children weighing over 15 kg** In 2020, ARS Phar...
Reuters
54 minutes ago
TD Cowen sees upside for US refiners post Ukraine's attacks on Russian refineries
** TD Cowen says U.S. refiners have regained footing after a tepid start to Q3, with Ukraine's recent attacks on Russian refineries supporting the margin environment, and setting up a bullish 6 to 12 months for the group** "The attacks could bridge an otherwise weaker period, support refinin...
Reuters
55 minutes ago
Retired and Afraid of Spending Money? Here's How "Die with Zero" May Change the Way You Think.
Key PointsA phenomenon called the "retirement consumption gap” occurs when you have the financial means to spend more but feel frozen in place. "Die with Zero" dares you to challenge yourself to spend money on experiences you’ll never forget.If your goal is to overcome the fear of spending, you may ...
The Motley Fool
an hour ago
What's Behind Nvidia's Huge Artificial Intelligence (AI) Investment in the U.K.?
In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA). To learn more, check out the short video, consider subscribing, and click the special offer link below.*Stock prices used were the after-market prices of Sept. 16, 2025. The video was published on Sept. 16, 2025.Where to inv...
The Motley Fool
an hour ago
9 Under-the-Radar AI Stocks to Buy Now
Key PointsThese stocks range from $270 million to $22 billion in market cap, providing AI exposure without mega-cap concentration risk. Each targets specific AI niches -- from edge chip design to credit decisioning to IoT platforms -- rather than competing head-on with giants.Many generate real reve...
The Motley Fool
an hour ago
1
1
/
4204
2
3
4
5
...
4204
next page
KeyAI
Please log in to use KeyAI
Log in
Sign Up